More Power to You  
      Site Map | Search  

 home Company Products Diabetes Care Hospital Products
  Contact Us
  About LifeScan
  Our Credo
 

Press Releases

  Community
  EHS Policy
  Safe Harbor Policy
  Lancet Disposal
  Distribution Policy
  Transparency
  Medical Education
  Investor Relations
  LifeScan Careers
  Around the World

LifeScan

 

Press Releases

LIFESCAN INTRODUCES HEELSTICK DEVICE FOR NEWBORNS
--UnistikŪ 2 Neonatal Designed to Reduce Risk of Accidental Needlesticks For Healthcare Workers--

MILPITAS, Calif., April 12, 2000 -- LifeScan, Inc. has introduced Unistik® 2 Neonatal, a single-use, disposable lancing device designed to provide greater protection for infants and for healthcare professionals who need to obtain patient blood samples for glucose and other blood-based tests.

Unistik 2For infants, the National Committee for Clinical Laboratory Standards (NCCLS) recommends a penetration depth of no more than 2.0 mm on heelsticks. Unistik 2 Neonatal helps lessen the risk of heel injury by providing a consistent and shallower penetration depth of only 1.8 mm, well within the NCCLS standard. The device's side triggering action was also designed to help minimize downward pressure of the device on an infant's heel during lancing.

For healthcare professionals, the Unistik 2 Neonatal provides "sharps" protection, featuring a needle that retracts after use. This feature was incorporated to reduce the risk of accidental needlesticks from used sharps. It is estimated that every year, between 600,000 and 800,000 healthcare workers accidentally stick themselves, posing a significant threat for cross-infection by bloodborne pathogens, such as hepatitis B, hepatitis C, HIV and antibiotic-resistant strains of bacteria.

As a result, both the Occupational Safety and Health Administration and the Centers for Disease Control and Prevention have issued recommendations to make the use of devices with sharps protection a requirement at hospitals throughout the United States. Five states -- California, Maryland, New Jersey, Texas and Tennessee -- have already enacted needle safety laws, and at least 16 other states are considering similar legislation.

"The risk of injury from sharp instruments is a daily reality for healthcare workers," stated Debbie Frantz, product manager at LifeScan. "LifeScan is pleased to be introducing a lancing device designed to reduce that risk for our customers."

The leading maker of blood glucose monitoring systems for hospital point-of-care testing*, LifeScan is part of the Johnson & Johnson family of diagnostic companies, which includes Ortho-Clinical Diagnostics. For more information on LifeScan and its products, visit LifeScan.com on the World Wide Web.

*Reference: DDD database of IMS Health for combined test strips and meters, as of June 1999.


Press Release Index arrow

  Accessibility E-mail This Print This
 
 

The health information on this Web site is for general background purposes and is not a substitute for medical advice or treatment for specific conditions. Seek prompt medical attention for health care questions you have. Consult your physician before making changes to your medication, diet, fitness program, or blood glucose testing schedules.